Related Experiment Videos
[Experience in treating psoriasis patients with the preparation Ditrastic]
Vestnik Dermatologii I Venerologii
|January 1, 1989
Summary
Ditrastic, a psoriasis treatment containing ditranol, demonstrated high effectiveness in clinical trials. The majority of patients experienced significant improvement or complete resolution of their skin condition.
Area of Science:
- Dermatology
- Pharmacology
Context:
- Psoriasis is a chronic autoimmune disease affecting the skin.
- Current treatments for psoriasis vary in efficacy and side effect profiles.
Purpose:
- To analyze the clinical trial results of Ditrastic, a new therapeutic agent for psoriasis.
- To evaluate the efficacy and convenience of Ditrastic in outpatient settings.
Summary:
- Clinical trials involving 59 patients treated with Ditrastic (1.5% or 3% ditranol) were analyzed.
- Complete resolution of psoriasis eruptions was observed in 43 patients (73%).
- Significant improvement was noted in 10 patients (17%), partial effect in 4 (7%), and no effect in 2 (3%).
Impact:
- Ditrastic proves to be a highly effective treatment for psoriasis.
- The drug's convenience supports its use in outpatient therapy, potentially improving patient management and quality of life.